Skip to Content

iShares Genomics Immnlgy & Hlthcr ETF IDNA

Quantitative rating as of | See iShares Investment Hub

Morningstar’s Analysis IDNA

Will IDNA outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.



Increased confidence in iShares Genomics Immnlgy & Hlthcr ETF's prospects relative to its Morningstar Category peers leads to an upgrade in this strategy's Morningstar Quantitative Rating to Silver from Bronze. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

Unlock our full analysis with Morningstar Investor